Physician profile
Robert A Hoffman
NPI 1174571731
$5,405.80
in general payments reported to CMS, 2019-2025
14 companies · $902 in 2025
The $902 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $90.99 · 2021: $757 · 2022: $1,330 · 2023: $198 · 2024: $579 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,401 · Entertainment: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.79 |
| Entertainment | $278.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,518.84 | 2019-2025 | Hydrus Microstent, Precision7, Voyager Dslt |
| Johnson & Johnson Vision Care, INC. | $1,825.81 | 2019-2025 | Acuvue |
| Optos, INC. | $278.57 | 2024-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $167.18 | 2019-2024 | Myday Contact Lens |
| Sight Sciences, INC. | $101.11 | 2022 | |
| Oyster Point Pharma, INC. | $97.50 | 2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $96.13 | 2019 | |
| Bausch & Lomb Americas INC. | $74.83 | 2024 | Infuse |
| Glaukos Corporation | $70.30 | 2025 | Idosetr |
| Genentech USA, INC. | $54.11 | 2019 | |
| Abb Con-Cise Optical Group LLC | $51.74 | 2021-2022 | |
| Almatica Pharma LLC | $33.00 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.44 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.